1. Home
  2. ASH vs ALKS Comparison

ASH vs ALKS Comparison

Compare ASH & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASH
  • ALKS
  • Stock Information
  • Founded
  • ASH 1924
  • ALKS 1987
  • Country
  • ASH United States
  • ALKS Ireland
  • Employees
  • ASH N/A
  • ALKS N/A
  • Industry
  • ASH Specialty Chemicals
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASH Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • ASH Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • ASH 4.1B
  • ALKS 4.8B
  • IPO Year
  • ASH N/A
  • ALKS 1991
  • Fundamental
  • Price
  • ASH $76.19
  • ALKS $27.91
  • Analyst Decision
  • ASH Buy
  • ALKS Buy
  • Analyst Count
  • ASH 7
  • ALKS 12
  • Target Price
  • ASH $102.50
  • ALKS $35.42
  • AVG Volume (30 Days)
  • ASH 453.9K
  • ALKS 1.9M
  • Earning Date
  • ASH 11-06-2024
  • ALKS 10-24-2024
  • Dividend Yield
  • ASH 2.14%
  • ALKS N/A
  • EPS Growth
  • ASH 1.05
  • ALKS 55.25
  • EPS
  • ASH 3.35
  • ALKS 1.97
  • Revenue
  • ASH $2,113,000,000.00
  • ALKS $1,505,121,000.00
  • Revenue This Year
  • ASH $1.09
  • ALKS N/A
  • Revenue Next Year
  • ASH $4.54
  • ALKS N/A
  • P/E Ratio
  • ASH $22.74
  • ALKS $14.17
  • Revenue Growth
  • ASH N/A
  • ALKS N/A
  • 52 Week Low
  • ASH $75.04
  • ALKS $22.22
  • 52 Week High
  • ASH $102.50
  • ALKS $32.88
  • Technical
  • Relative Strength Index (RSI)
  • ASH 29.63
  • ALKS 49.54
  • Support Level
  • ASH $76.68
  • ALKS $27.11
  • Resistance Level
  • ASH $78.20
  • ALKS $28.47
  • Average True Range (ATR)
  • ASH 1.74
  • ALKS 0.91
  • MACD
  • ASH -0.61
  • ALKS -0.07
  • Stochastic Oscillator
  • ASH 8.30
  • ALKS 46.89

About ASH Ashland Inc.

Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: